SEC Form 4 · accession 0001209191-15-066214
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Ann Merrifield
Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 11:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| JNP Stock on Open MarketF1 | Aug 13, 2015 | P | 1,000 | $9.96 | A | 1,000 | D | |
| JNP Stock on Open MarketF2 | Aug 14, 2015 | P | 2,000 | $9.87 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at an average price of $9.96. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.
- F2This transaction was executed in multiple trades at an average price of $9.87. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.